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1. Introduction
  Lead is a heavy metal occurring naturally as a sulfide 
in galena. It is a soft, bluish-white, silvery-gray metal 
prevalent in water and soil. Generally, lead compounds are 
emitted into the atmosphere from three sources; gasoline-
powered vehicles, industrial processes, and incineration[1, 2]. 
Human exposure occurs primarily through air, drinking 
water, diet, and dust from industrial and motor vehicle 
sources[3]. More than 95% of lead is inorganic and occurs as 
a lead salt[4]. Food can be contaminated by lead from lead 
solder in cans or other food containers. It is also found in 
paints and glazes used in making pottery and ceramic ware. 
  Lead poisoning can be classified into acute and chronic 
types. Most cases of acute poisoning occur among specific 
groups such as workers renovating old buildings[5]. The 
classical clinical features of acute poisoning are abdominal 
colic and constipation. These symptoms are largely due 
to irritation of the alimentary tract. If sufficient lead is 
retained after a single exposure, a syndrome identical to 
chronic intoxication may develop with symptoms including 
leg cramps, muscle weakness, paresthesia, CNS depression, 
coma, and death within one to two days. Chronic lead 
poisoning has an impact on more populations than acute 
type as a result of environmental pollution. Besides the 
non-specific symptoms described above, chronic lead 
poisoning has been shown to affect many organ systems, 
for example, the hematopoietic, reproductive, central and 
peripheral nervous systems and renal tissue[1]. In the oral 
cavity, a blue gingival lead line (Burton’s line) has been 
shown to be a valuable clinical sign of moderate chronic 
lead poisoning[6]. Other oral manifestations of lead poisoning 
include a heavy coating on the tongue and tremor of the 
tongue on thrusting, advanced periodontal disease, excessive 
salivation, metallic taste and ulcerative stomatitis [7].
  Ulcerative stomatitis may develop when the oral mucosa 
has a long term direct contact to lead. It is an inflammation 
condition of the oral mucosa characterized by ulcers on 
the cheek, tongue and lips. During inflammation, several 
cytokines and chemokines produced by a variety of cell 
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types such as macrophages, fibroblasts and keratinocytes 
are involved in this process. Among these mediators, 
interleukin-8 (IL-8) is one of the best studied chemokines 
involved in ulcerative stomatitis[8,9]. One study has 
demonstrated the elevation of serum IL-8 in patients with 
recurrent aphthous ulcer (RAU), a common type of painful 
ulcerative stomatitis affecting the oral mucosa[8]. In addition, 
IL-8 is considered to be a marker in monitoring the 
disease’s activity [10,11]. 
  Since the epithelium is the first barrier of oral mucosa 
exposed to lead, it is important to study how keratinocytes, 
the main cell type of the epithelium, respond to this toxic 
metal, particularly their ability to produce IL-8. To the best 
of our knowledge, the effect of lead on normal human oral 
keratinocytes (NHKs) has not been studied. Therefore, the 
purpose of the present study was to investigate the effect of 
lead on the production of IL-8 in NHKs. Moreover, the effect 
on cell proliferation was also examined since the level of 
IL-8 may be related to the number of cells.
 
2. Materials and methods
2.1. Lead preparation
  Lead glutamate was used in this study. A stock solution, 
containing 4.5伊10-2 M lead nitrate (Sigma Chemical 
Company, St. Louis, USA) and 5伊10-2 M glutamic acid in 
deionized water, was prepared.
2.2. Cell culture
  NHKs were prepared as outgrowths from normal human 
buccal mucosa collected from the Department of Oral 
Surgery, Faculty of Dentistry, Mahidol University. The 
preparation of the cells from explant cultures was modified 
from that described by Freshney[11]. Briefly, the tissue 
was finely chopped into small pieces and placed in 25 cm2 
culture flasks. Then keratinocyte growth medium (KGM) 
was gently added. KGM consisted of 1 g/mL minimum 
essential medium (Gibco BRL, NY, USA), 2.2 mg/mL NaHCO3 
(Merck KgaA, Darmstadt, Germany) supplemented with 
100 IU/mL penicillin, 100 毺g/mL streptomycin, 2.5 毺g/
mL fungizone (Gibco BRL), 1.8伊10-4 M adenine, 0.5 毺g/mL 
hydrocortisone, 5毺g/ml insulin, 10
-10 M cholera toxin and 
10 ng/mL epidermal growth factor (all obtained from Sigma). 
This medium was further supplemented with 10% fetal calf 
serum (Gibco BRL).
  After one week, the outgrowth of cells was observed and 
the medium was changed. Cultures were fed every 2 to 3 
days for 18 to 21 days until subconfluent cell monolayers 
were formed. The cells were used within two passages. 
2.3. Treatment
  The cultured NHKs were seeded in 96-well culture plates 
(8 伊103 cells/mL) with serum-free medium supplemented 
with antibiotic and fungizone; the cells were incubated 
overnight. On the following day, the medium was changed 
and supplemented with three concentrations of lead 
glutamate: 4.5伊10-5 M, 4.5伊10-6 M, and 4.5伊10-7 M. NHKs 
grown in 5 伊10-5 M glutamic acid were used as control.
2.4. IL-8 determination
  The level of IL-8 secreted in the culture supernatants 
was evaluated at 12 and 24 hours. The amount of IL-8 was 
assessed by quantitative sandwich enzyme immunoassay 
technique (IL-8 ELISA, Biosource International, Belgium) 
according to the manufacturer’s protocol.
2.5. Cell proliferation study
  Cell proliferation was evaluated by the MTT colorimetric 
assay. The culture media was removed at 12 and 24 
hours after inoculation with lead glutamate. A 50 毺L of 
MTT solution (3-(4, 5- Dimethylthiazole-2-yl) - 2, 5- 
diaphenyltetrazolium bromide) (Sigma) was added to the 
culture wells. The amount of formazan produced was 
assayed by measuring the density at 570 nm using a 毺
-Quant microplate reader (Biotek Instruments, Inc., USA).
2.6. Statistical analysis
  Three cultures were used for each experiment, and three 
independent experiments were performed. Statistical analysis 
was carried out by one-way ANOVA. Tests of differences of 
the treatments were analyzed by Duncan’s test and a value of 
P<0.05 was considered as statistically significance.
 
3. Results
  NHKs were exposed to three concentrations of lead 
glutamate (4.5伊10-5 M, 4.5伊10-6 M, and 4.5伊10-7 M). Rapid 
accumulation of IL-8 was detected in culture supernatants 
of NHKs treated with lead at all concentrations after 12 hour 
of exposure, and this elevation was also observed at 24 hour 
incubation period in a dose-dependent manner (Table 1). 
The optimal concentration for IL-8 stimulation in this study 
was 4.5伊10-5 M lead glutamate. Compared to the control, 
a significant increase in cell numbers was observed only 
after 24 hour exposure to 4.5伊10-5 M lead glutamate (P<0.05) 
(Table 2). No significant differences were found for the 4.5伊
10-6 M and 4.5伊10-7 M lead glutamate groups. 
 
4. Discussion
  The results presented here demonstrates that in a primary 
cell culture system NHKs have the capacity to secrete 
IL-8. This capacity can be enhanced by lead glutamate at 
concentrations between 10-5 M to10-7 M corresponding to 
those of unsafe levels (曒 0.5 毺M)[6] and the levels (0.5-3 毺
M) in human blood with varied effects on brain function[12]. 
Induction of cell proliferation was observed only after 24 
hour exposure to high lead concentration (10-5 M). Thus, we 
propose that the lead induced elevation of IL-8 observed in 
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this study is not related to an increase of cell proliferation.   
  IL-8 is an important mediator of host response to injury 
and inflammation[13]. It possesses diverse functions as a 
neutrophil activator and a chemo-attractant for neutrophils, 
T cells, and basophils[14]. IL-8 is produced by a variety of cell types 
including monocytes/macrophages, T cells, neutrophils, endothelial 
cells, fibroblasts, and keratinocytes [9,13,15]. In healthy tissues, 
IL-8 is barely detectable, but is rapidly induced by 10- to 
100-fold in response to pro-inflammatory cytokines, such as 
tumor necrosis factor-毩 (TNF-毩) or IL-1毬, bacterial or 
viral products, and cellular stress[16]. A high level of  IL-8 in 
serum has been found to be significantly associated with the 
presence of oral ulcer[8,9] and IL-8 activated neutrophils is 
believed to be a major source of enzymes involved in tissue 
destruction[17]. Therefore, the elevation of IL-8 secreted 
by oral keratinocytes may be the initial sign of the acute 
inflammatory response following lead exposure to oral 
mucosal surfaces and may reflect the pathogenesis of lead 
stomatitis in the oral cavity. It appears that IL-8 plays an 
important role both in lead-induced stomatitis and RAU, 
thus the treatment of RAU may be applied to lead-induced 
stomatitis.
  In the present study, the ability of lead at high 
concentration to increase oral keratinocyte proliferation 
is similar to our previous study in dental pulp cells[18]. 
However, the mechanism underlying this effect remains 
unknown. Based on our result, the induction of keratinocyte 
proliferation observed at 10-5 M lead glutamate is not likely 
to be relevant to the elevation of IL-8 since cell numbers did 
not increase in many conditions that IL-8 production was 
up-regulated. It should be noted that several growth factors 
and cytokines such as epidermal growth factor, fibroblast 
growth factor-2, transforming growth factor-beta, IL-1, 
IL-6 or TNF-毩 can promote keratinocyte proliferation[19]. 
Additionally, cell proliferation can be influenced by other 
mechanisms such as up-regulation of growth factor receptors 
or cytokine receptors and inhibition of the apoptosis 
pathway[20]. Interestingly, the lead-induced cell proliferation 
may be associated with the carcinogenic mechanisms of 
lead. The issue of potential carcinogenic effects of lead has 
received renewed focus, leading to the classification Group 
2A (probably carcinogenic to humans) by IARC and Group 2 
(considered to be  carcinogenic to humans) by the German 
MAK Commission[21, 22]. These classifications were mainly 
based on animal experiments, where increased tumor 
incidences were observed in multiple organs, including the 
brain and kidney. In mammalian AS52 cells, lead chloride 
induced mutations in a dose-dependent manner, starting at 
the non-cytotoxic concentration of 10-7 M[23]. Furthermore, it 
has been demonstrated that lead at high concentrations has 
the ability to bind to DNA, change DNA conformation[24] and 
break nucleic acids[25]. Recent research suggested that lead 
may act as a human carcinogen by permitting or enhancing 
carcinogenic events at cellular or molecular levels[26]. Taken 
these evidences with our results showing that lead at high 
level could induce cell proliferation, it is possible that lead 
may be related to the pathogenesis of oral squamous cell 
carcinoma particularly in people who has been exposed 
to lead. However, further studies are needed to determine 
the exact role and mechanisms of this lead-induced 
hyperproliferation in NHK. 
  In summary, the elevation of IL-8 production by oral 
keratinocytes was observed at various lead concentrations. 
However, induction of cell proliferation was demonstrated 
only at a high lead concentration. These results indicate 
that the increased production of IL-8 might be involved in 
the initiation or pathogenesis of lead stomatitis found in the 
oral cavity while at high concentration, induction of cell 
proliferation may be an evidence of lead carcinogenicity.
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Table 1
IL-8 production in culture supernatants of NHKs after treatment with various concentrations of lead glutamate.
Lead exposure time (h)
IL-8 (pg/mL)
control
Lead (M)
4.5伊10-5 4.5伊10-6 4.5伊10-7
12   652.30依35.29  917.70依50.35*   886.84依88.15*   885.11依73.16*
24 1099.90依92.81 1334.17依25.42* 1235.12依33.17* 1190.05依42.56*
Data are expressed as mean + SD of triplicate wells.  *statistically significant difference from control (P<0.05).
Table 2
The number of NHKs after treatment with various concentrations of lead glutamate.
Lead exposure time (h)
Cell number (伊103 cell)
control
Lead (M)
4.5伊10-5 4.5伊10-6 4.5伊10-7
12              7.21依1.39 7.35依0.76               7.51依1.25               7.13依1.42
24              7.78依0.23 8.89依0.51*               7.97依0.76              8.10依1.57
Data are expressed as mean + SD of triplicate wells, * statistically significant difference from control (P<0.05).
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